Quantification of Azithromycin in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry: Application to a Bioequivalence Study

 

 Buy Article Permissions and Reprints

Abstract

A specific, sensitive and rapid liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method has been developed and validated for the determination of azithromycin in human plasma. After deproteinizing the plasma sample with methanol, azithromycin and internal standard (IS: roxithromycin) were separated using a mobile phase comprised of acetonitrile : ammonium acetate buffer (50 mM, containing 0.05% acetic acid)=85:15 on a Hypersil GOLD C₁₈ column (50 mm×2.1 mm ID, dp 1.9 μm). Detection was performed with a tandem mass spectrometer by selective reaction monitoring (SRM) through electrospray ionization. Target ions were monitored at [M+H]⁺ m/z 749.5→591.5 and 837.7→679.5 in positive electrospray ionization (ESI) mode for azithromycin and IS respectively. Linearity was established for the range of concentrations 2–800 ng/mL with a coefficient of correlation (r) of 0.9996. The lower limit of quantification (LLOQ) was identifiable and reproducible at 2.0 ng/mL. Both intra- and inter-batch standard deviations were less than 15%. The validated method was successfully applied to study the comparative bioavailability of azithromycin for suspension in test vs. reference in healthy Chinese volunteers through the statistical comparison of pharmacokinetic parameters obtained with the two formulations.

• References

• 1 Ballow CH, Amsden GW. Azithromycin: the first azalide antibiotic. Ann Pharmacother 1992; 26: 1253-1261
  PubMedGoogle Scholar
• 2 Yang ZY, Wang L, Tang X. Determination of azithromycin by ion-pair HPLC with UV detection. J Pharm Biomed Anal 2009; 49: 811-815
  CrossrefPubMedGoogle Scholar
• 3 Zubata P, Ceresole R, Rosasco MA et al. A new HPLC method for azithromycin quantitation. J Pharm Biomed Anal 2002; 27: 833-836
  CrossrefPubMedGoogle Scholar
• 4 Supattanapong S, Konsil J. Solid phase extraction and high performance liquid chromatography for the determination of azithromycin in human plasma. Southeast Asian J Trop Med Public Health 2008; 39: 978-987
  PubMedGoogle Scholar
• 5 Gandhi R, Kaul CL, Panchagnula R. Validated LC method for in-vitro analysis of azithromycin using electrochemical detection. J Pharm Biomed Anal 2000; 23: 1073-1079
  CrossrefPubMedGoogle Scholar
• 6 Wu Y, Ji X, Hu S. Studies on electrochemical oxidation of azithromycin and its interaction with bovine serum albumin. Bioelectrochemistry 2004; 64: 91-97
  CrossrefPubMedGoogle Scholar
• 7 Bahrami G, Mirzaeei S, Kiani A. High performance liquid chromatographic determination of azithromycin in serum using fluorescence detection and its application in human pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 820: 277-281
  PubMedGoogle Scholar
• 8 Sastre TJ, Guchelaar HJ. Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl chloride and fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 1998; 720: 89-97
  PubMedGoogle Scholar
• 9 Wilmsa E, Trumpie H, Veenendaal W et al. Quantitative determination of azithromycin in plasma, blood and isolated neutrophils by liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl-chloride and fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 814: 37-42
  PubMedGoogle Scholar
• 10 Bahrami G, Mohammadi B. A new on-line, in-tube pre-column derivatization technique for high performance liquid chromatographic determination of azithromycin in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 830: 355-358
  PubMedGoogle Scholar
• 11 Chen BM, Liang YZ, Chen X et al. Quantitative determination of azithromycin in human plasma by liquid chromatography–mass spectrometry and its application in a bioequivalence study. J Pharm Biomed Anal 2006; 42: 480-487
  CrossrefPubMedGoogle Scholar
• 12 Wang YH, Chen JJ, Chen BM et al. Determination of azithromycin in human plasma by HPLC-MS and its relative bioavailability. Chin Pharm J 2006; 4: 51-54
  PubMedGoogle Scholar
• 13 Liu F, Xu Y, Huang J et al. Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma. Biomed Chromatogr 2007; 21: 1272-1278
  CrossrefPubMedGoogle Scholar
• 14 Nirogia RVS, Kandikere VN, Shukla M, Mudigonda K et al. Sensitive and selective liquid chromatography–tandem mass spectrometry method for the quantification of azithromycin in human plasma. Anal Chim Acta 2005; 553: 1-8
  CrossrefPubMedGoogle Scholar
• 15 Yüzüak N, Özden T, Eren S et al. Analysis of azithromycin in human plasma by LC-MS-MS. Chromatographia 2007; 66: 5115-5118
  PubMedGoogle Scholar
• 16 Xu F, Zhang Z, Bian Z et al. Azithromycin quantitation in human plasma by high-performance liquid chromatography coupled to electrospray mass spectrometry: application to bioequivalence study. J Chromatogr Sci 2008; 46: 479-484
  PubMedGoogle Scholar
• 17 Barrett B, Borek-Dohalský V, Fejt P et al. Validated HPLC-MS-MS method for determination of azithromycin in human plasma. Anal Bioanal Chem 2005; 383: 210-217
  CrossrefPubMedGoogle Scholar
• 18 Xue-Min Z, Jie L, Juan G et al. Determination of azithromycin in human plasma by LC-MS-MS and its pharmacokinetics. Pharmazie 2007; 62: 255-257
  PubMedGoogle Scholar
• 19 Chen L, Qin F, Ma Y et al. Quantitative determination of azithromycin in human plasma by ultraperformance liquid chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 855: 255-261
  PubMedGoogle Scholar